School of Medicine


Showing 41-50 of 227 Results

  • Catherine Duarte

    Catherine Duarte

    Instructor, Epidemiology and Population Health

    BioDr. Catherine Duarte is an IDEAL Provostial Fellow based in the Department of Epidemiology & Population Health at Stanford University’s School of Medicine. She received her PhD in Epidemiology from the University of California, Berkeley School of Public Health and her Master of Science in Social and Behavioral Sciences from the Harvard T.H. Chan School of Public Health. As a doctoral student, Duarte was selected to the Robert Wood Johnson Foundation’s Health Policy Research Scholars Program - a national leadership training program bringing together scholars from across academic disciplines whose applied research seeks to contribute to building healthier and more equitable communities. Duarte’s work specifically focuses on examining how education and legal system policy and practices may shape racial health inequities throughout the life course. In so doing, her work aims to contribute to systems-level interventions designed to support health equity and wellbeing for collective thriving.

  • Ramzi Emanuel Dudum

    Ramzi Emanuel Dudum

    Clinical Scholar, Medicine - Cardiovascular Medicine
    Postdoctoral Scholar, General Internal Medicine
    Masters Student in Health Policy, admitted Autumn 2022

    BioDr. Dudum is a cardiologist, public health specialist, and outcomes researcher working to develop novel risk prediction methods and implementation strategies to create practices and systems that allow for reductions in cardiovascular disease. He completed a Masters in Public Health at Johns Hopkins concentrating in epidemiology and biostatistics and a Doctorate of Medicine at George Washington University. He is currently a candidate for a Masters of Science in Health Policy at Stanford.

    He completed internal medicine residency training as part of the Osler Medical Service, where he worked under the mentorship of Drs. Roger Blumenthal and Michael Blaha to study improving cardiovascular risk prediction and coronary artery calcium. Given his focus on population health and implementation science, he also helped launch and refine risk adjustment tools and implemented guideline-directed medical care pathways. During his time there, he was recognized for his clinical acumen and dedication to patient care.

    He came to Stanford for his cardiovascular medicine fellowship and continued research in coronary artery calcium under the mentorship of Drs. David Maron and Fatima Rodriguez while also conducting cardiovascular health implementation science work under the mentorship of Dr. Steve Asch. He serves as the co-investigator of a prospective randomized trial testing the effects of notification of incidental coronary artery calcium on statin initiation rates among those with and without cardiovascular disease (NCT 05588895). He has worked with hospital leaders to implement digital health and artificial intelligence tools, creating the infrastructure for the prospective use of AI-algorithms on radiology studies. As a preventive cardiologist and population health specialist, he leads efforts in the preventive cardiology section related to improving cardiovascular health.

  • Raj Fadadu

    Raj Fadadu

    Casual - Non-Exempt, Epidemiology and Population Health

    BioRaj Fadadu is currently in his final year of medical school at the University of California, San Francisco (UCSF) School of Medicine and interested in pursuing a career in dermatology.

    He has experience conducting epidemiology research projects, particularly related to environmental exposures and skin diseases (e.g., atopic dermatitis and psoriasis) and epigenetics (e.g., EWAS and epigenetic age acceleration). He also holds leadership roles in local and national organizations involved in climate change advocacy and education, working to improve community and patient health. In addition, he is a strong advocate for health equity and increasing access to medical care for people experiencing homelessness and has implemented innovative projects to do so while serving as an Albert Schweitzer Fellow and Director of student-run free clinics in Berkeley, CA. For his impactful work, he was named an Environmental Education "30 Under 30" in 2022 and received the Excellence in Climate Leadership Award from the American Public Health Association in 2022 and Emerging Physician Leader Award from Health Care Without Harm in 2021.

    He received a M.S. degree in Health and Medical Sciences (with concentrations in Environmental Research and Healthcare Management) from the UC Berkeley School of Public Health and received a B.A. degree in Public Health from UC Berkeley (graduated with Highest Distinction and Research Honors).

  • Mohsen Fathzadeh

    Mohsen Fathzadeh

    Genomic Scientist, Epidemiology and Population Health

    BioMohsen Fathzadeh, a seasoned Medical Geneticist, has dedicated over 20 years to genomic science. His academic journey began at Yale University, where he completed his Ph.D. thesis under Prof. Arya Mani, focusing on a genetic form of familial Metabolic Syndrome. From 2015 to 2021, he served as a Postdoctoral Fellow at Stanford University, specializing in Cardiovascular Medicine, Psychiatry, and Public Health Sciences. During this tenure, he conducted comprehensive functional genomic analyses under the mentorship of esteemed professors.

    Mohsen's collaborative efforts with Merck & Co., Inc. led to the identification of a gene regulator associated with body fat distribution. His research scope also includes the characterization of genes linked to insulin resistance and obesity. Recently, he explored the (epi)genetic link between newborn body fat distribution and high maternal gestational glucose levels, focusing on mother-child cohorts from diverse and underserved communities.

    His primary goal is to utilize his findings to enhance our understanding of the genes and evolutionary pathways influencing healthspan and age-related diseases, thereby improving patient lives.

    After completing his postdoctoral research in 2021, Mohsen spent two years in the biotech industry, specializing in genetic testing and variant assessment. He is currently affiliated with Stanford's Population Health Center, studying epigenetic disease mechanisms in mother-child cohorts.

    Outside his professional life, Mohsen leads an active lifestyle and enjoys learning about diverse cultures.

  • Zahra Fazal

    Zahra Fazal

    Masters Student in Epidemiology and Clinical Research, admitted Autumn 2022

    BioZahra Fazal, from Morogoro, Tanzania, is pursuing a master’s degree in epidemiology and clinical research at Stanford School of Medicine as a Knight Hennessey scholar. She graduated from the University of British Columbia (UBC), Canada with a bachelor’s degree with distinction in Global health and nutrition as a Karen McKellin International Leader of Tomorrow scholar. Zahra plans to apply her graduate degree towards researching health inequities amongst under-served populations and advocating for data-driven policy change within Sub-Saharan Africa. During her undergraduate degree, Zahra founded a club for first-generation and low-income (FGLI) students, launched a podcast and hosted Canada’s first conference for FGLI students bringing together universities and education ministers across Canada. Inspired by her advocacy, UBC established a scholarship for FGLI students. Zahra was also a research assistant on a patient-partner project at Arthritis Research Canada investigating COVID-19 outcomes in patients with immunosuppression within Canada. Zahra has received the UBC Dean Blythe Eagles Medal, UBC International Community Achievement Award and is a 2022 Rhodes East Africa finalist.

  • Paul Graham Fisher, MD

    Paul Graham Fisher, MD

    Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health

    Current Research and Scholarly InterestsClinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors and other cancers in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies.